EJP PHARMACEUTICAL ApS: Financial statements 2024
CVR: 87923614
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -32,946 and a net result of DKK 414,071 compared with DKK 453,582 the year before. Equity in the 2024 report amounted to DKK 4,428,783. The solvency ratio was 98.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -32,946
- Profit/Loss
- DKK 414,071
- Equity
- DKK 4,428,783
- Total Assets
- DKK 4,513,036
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -33 t. | 414 t. | 4.4 mio. | 1 |
| 2023 | - | -34 t. | 454 t. | 4.1 mio. | 1 |
| 2022 | - | -49 t. | -478 t. | 6.7 mio. | 1 |
| 2021 | - | -40 t. | 443 t. | 7.3 mio. | 1 |
| 2020 | - | -75 t. | -140 t. | 6.9 mio. | 1 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
EJP PHARMACEUTICAL ApS has published its annual report for 2023. Gross profit came to DKK -34,271, and the net result was DKK 453,582.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity in the 2025 report amounted to DKK 814,282.